•Serum anti-MAA (IgA/IgG) Ab increased in RA patients prior to RA diagnosis (vs. matched control) but detected later than ACPA/RF; pre-diagnosis differences in anti-MAA most striking in ACPA+ individuals. Here, CD79A is linked to rheumatoid arthritis.